To read the full story, subscribe or sign in.

Samsara expands footprint in China for prosthetic eye devices with partner Lansheng Medical

June 13, 2022

Samsara Vision Inc. signed a deal with China’s Lansheng Medical Corp. (Myvision) to bring Samsara’s next-generation visual prosthetic devices to mainland China, Macau, the Hanain Province, and Hong Kong.

BioWorld MedTech Deals and M&A Asia-Pacific China

Today's news in brief

BioWorld

BioWorld briefs for Aug. 7, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for August 7, 2025.

Chimerix buyout a win for Jazz with FDA nod for rare glioma drug

BioWorld

Jazz Pharmaceuticals plc is prepped and ready for launch following U.S. FDA accelerated approval of dordaviprone as the first systemic therapy for H3 K27M-mutant...

FDA defends use of PFAS in medical devices

BioWorld MedTech

The U.S. FDA has staked out a position on the use of per- and polyfluoroalkyl substances in medical devices, declaring that the evidence offers no reason to...

Illustration of Microglia cells (red) in Alzheimer´s disease

Two cancer drugs combined modify Alzheimer’s disease in mice

BioWorld

Current treatments for Alzheimer’s disease have limited effects. While they can slow cognitive decline or alleviate symptoms, they do not reverse this complex...